Westfield Capital Management CO LP Jazz Pharmaceuticals PLC Transaction History

Westfield Capital Management CO LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $139 Million - $164 Million	-1,143,835 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$115.94 - $166.74 $3.61 Million - $5.19 Million	31,100 Added 2.79%	1,143,835 $142 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $36.8 Million - $41.3 Million	228,774 Added 25.88%	1,112,735 $187 Million
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $46.7 Million - $58.5 Million	-319,444 Reduced 26.55%	883,961 $152 Million
Q1 2018 May 14, 2018	SELL	$135.59 - $157.16 $3.68 Million - $4.27 Million	-27,167 Reduced 2.21%	1,203,405 $182 Million
Q4 2017 Feb 13, 2018	SELL	$131.06 - $150.39 $27.2 Million - $31.3 Million	-207,909 Reduced 14.45%	1,230,572 $166 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $205 Million - $224 Million	1,438,481	1,438,481 $210 Million

513

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.61B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.